Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.

Collins IJ, Judd A, Gibb DM.

Curr Opin HIV AIDS. 2014 Jan;9(1):87-94. doi: 10.1097/COH.0000000000000027. Review.

PMID:
24247666
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.

Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD004772. doi: 10.1002/14651858.CD004772.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;5:CD004772.

PMID:
22786492
[PubMed - indexed for MEDLINE]
3.

Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.

Siegfried N, Davies MA, Penazzato M, Muhe LM, Egger M.

Cochrane Database Syst Rev. 2013 Oct 10;10:CD010309. doi: 10.1002/14651858.CD010309.pub2. Review.

PMID:
24114324
[PubMed - indexed for MEDLINE]
4.

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.

Picat MQ, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, Nahirya Ntege P, Gibb DM, Thiebaut R, Walker AS, Klein N, Callard R; ARROW Trial Team.

PLoS Med. 2013 Oct;10(10):e1001542. doi: 10.1371/journal.pmed.1001542. Epub 2013 Oct 29.

PMID:
24204216
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

When to start, what to start and other treatment controversies in pediatric HIV infection.

Turkova A, Webb RH, Lyall H.

Paediatr Drugs. 2012 Dec 1;14(6):361-76. doi: 10.2165/11599640-000000000-00000.

PMID:
23013459
[PubMed - indexed for MEDLINE]
6.

Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.

Iwuji CC, Orne-Gliemann J, Tanser F, Boyer S, Lessells RJ, Lert F, Imrie J, Bärnighausen T, Rekacewicz C, Bazin B, Newell ML, Dabis F; ANRS 12249 TasP Study Group.

Trials. 2013 Jul 23;14:230. doi: 10.1186/1745-6215-14-230.

PMID:
23880306
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.

Babiker AG, Emery S, Fätkenheuer G, Gordin FM, Grund B, Lundgren JD, Neaton JD, Pett SL, Phillips A, Touloumi G, Vjechaj MJ; INSIGHT START Study Group.

Clin Trials. 2013;10(1 Suppl):S5-S36. doi: 10.1177/1740774512440342. Epub 2012 Apr 30.

PMID:
22547421
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

ARROW Trial team, Kekitiinwa A, Cook A, Nathoo K, Mugyenyi P, Nahirya-Ntege P, Bakeera-Kitaka S, Thomason M, Bwakura-Dangarembizi M, Musiime V, Munderi P, Naidoo-James B, Vhembo T, Tumusiime C, Katuramu R, Crawley J, Prendergast AJ, Musoke P, Walker AS, Gibb DM.

Lancet. 2013 Apr 20;381(9875):1391-403. doi: 10.1016/S0140-6736(12)62198-9. Epub 2013 Mar 7.

PMID:
23473847
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.

Siegfried N, Uthman OA, Rutherford GW.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008272. doi: 10.1002/14651858.CD008272.pub2. Review.

PMID:
20238364
[PubMed - indexed for MEDLINE]
10.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117
[PubMed - indexed for MEDLINE]
11.

Recent advances in pharmacovigilance of antiretroviral therapy in HIV-infected and exposed children.

Kenny J, Musiime V, Judd A, Gibb D.

Curr Opin HIV AIDS. 2012 Jul;7(4):305-16. doi: 10.1097/COH.0b013e328354da1d. Review.

PMID:
22678488
[PubMed - indexed for MEDLINE]
12.

Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study.

Collins IJ, Jourdain G, Hansudewechakul R, Kanjanavanit S, Hongsiriwon S, Ngampiyasakul C, Sriminiphant S, Technakunakorn P, Ngo-Giang-Huong N, Duong T, Le Coeur S, Jaffar S, Lallemant M; Program for HIV Prevention and Treatment Study Team.

Clin Infect Dis. 2010 Dec 15;51(12):1449-57. doi: 10.1086/657401. Epub 2010 Nov 5.

PMID:
21054181
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.

Pai NP, Tulsky JP, Lawrence J, Colford JM Jr, Reingold AL.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005482. Review.

PMID:
16235406
[PubMed - indexed for MEDLINE]
14.

Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study.

Puthanakit T, Ananworanich J, Vonthanak S, Kosalaraksa P, Hansudewechakul R, van der Lugt J, Kerr SJ, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Vibol U, Pruksakaew K, Suwarnlerk T, Apornpong T, Ratanadilok K, Paul R, Mofenson LM, Fox L, Valcour V, Brouwers P, Ruxrungtham K; PREDICT Study Group.

Pediatr Infect Dis J. 2013 May;32(5):501-8. doi: 10.1097/INF.0b013e31827fb19d.

PMID:
23263176
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.

O'Brien DP, Sauvageot D, Zachariah R, Humblet P; Medecins Sans Frontieres.

AIDS. 2006 Oct 3;20(15):1955-60.

PMID:
16988517
[PubMed - indexed for MEDLINE]
16.

Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.

Anglaret X, Scott CA, Walensky RP, Ouattara E, Losina E, Moh R, Becker JE, Uhler L, Danel C, Messou E, Eholié S, Freedberg KA.

Antivir Ther. 2013;18(1):45-55. doi: 10.3851/IMP2231. Epub 2012 Jul 18.

PMID:
22809695
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data.

HIV Paediatric Prognostic Markers Collaborative Study.

Lancet. 2005 Nov 26;366(9500):1868-74.

PMID:
16310553
[PubMed - indexed for MEDLINE]
18.

Response to planned treatment interruptions in HIV infection varies across childhood.

Paediatric European Network for Treatment of AIDS.

AIDS. 2010 Jan 16;24(2):231-41. doi: 10.1097/QAD.0b013e328333d343.

PMID:
20010073
[PubMed - indexed for MEDLINE]
19.
20.

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.

Walker AS, Prendergast AJ, Mugyenyi P, Munderi P, Hakim J, Kekitiinwa A, Katabira E, Gilks CF, Kityo C, Nahirya-Ntege P, Nathoo K, Gibb DM; DART and ARROW trial teams.

Clin Infect Dis. 2012 Dec;55(12):1707-18. doi: 10.1093/cid/cis797. Epub 2012 Sep 12.

PMID:
22972859
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk